That interview changed my point of view as well. It does indeed seem like hypocrisy, and like the competing and stronger drug companies set up this publication lynch. I can't believe that out of all the strong drug companies, the first time a drug was increased in price is this poor 2015 founded company. Why is it, that the first time we hear about this common practice in drug industry it's within this relatively new company?